Process For Appealing FDA Actions To Be Clarified, CDRH Ombudsman Says

FDA's device center is reworking procedures for resolving disputes between industry and FDA reviewers, and expanding the types of regulatory actions that can be appealed.

More from Archive

More from Medtech Insight